HematologyNews.net

Hematology Xagena

Xagena Mappa
Xagena Newsletter
OncologiaMedica.net
Medical Meeting

Search results for "Venous thromboembolism"

New pooled safety data from the RE-COVER and RE-COVER II phase III trials in acute deep vein thrombosis ( DVT ) and pulmonary embolism ( PE ) consistently favour treatment with Pradaxa ( Dabigatran et ...


Peripherally inserted central catheters ( PICCs ) are associated with an increased risk of venous thromboembolism. However, the size of this risk relative to that associated with other central venous ...


The results from the global phase 3 Hokusai-VTE study of 8,292 patients with either acute symptomatic deep vein thrombosis ( DVT ), pulmonary embolism ( PE ), or both, were presented at the ESC Congre ...


Immobilization of the lower leg is associated with venous thromboembolism ( VTE ). Low molecular weight Heparin ( LMWH ) is an anticoagulant treatment which might be used in adult patients with lower- ...


The FDA ( Food and Drug Administration ) has approved a Supplemental New Drug Application ( sNDA ) for Eliquis ( Apixaban ) for the treatment of deep vein thrombosis ( DVT ) and pulmonary embolism ( P ...


Final data from a phase 2 comparator-controlled study evaluating the incidence of venous thromboembolic events ( VTE ) in patients treated with ISIS-FXI Rx undergoing total knee replacement surgery, o ...


Venous and arterial thromboses have been regarded for many years as two different diseases requiring anticoagulant or antiplatelet treatment, respectively. Platelets have a role in venous thromboe ...